Cardiac Effect of FABP4 Inhibitor: A Novel Therapeutic Target for Diabetes Mellitus and Atherosclerosis

被引：0
|
作者：
Lamounier-Zepter, Valeria
Look, Christiane
Bornstein, Stefan R.
Morano, Ingo
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A483 / A483
页数：1
相关论文
共 50 条
  • [31] Associations between circulating levels of FABP4 and TNF receptors are more evident in patients with type 2 diabetes mellitus than in patients with type 1 diabetes mellitus
    Tanaka, Marenao
    Gohda, Tomohito
    Kamei, Nozomu
    Murakoshi, Maki
    Sato, Tatsuya
    Kubota, Mitsunobu
    Sanuki, Michiyoshi
    Ishiwata, Erika
    Endo, Keisuke
    Suzuki, Yusuke
    Furuhashi, Masato
    ENDOCRINE CONNECTIONS, 2024, 13 (11)
  • [32] Serum FABP4 Predicts Preeclampsia in Pregnant Women with Type 1 Diabetes
    Wotherspoon, Amy C.
    Holmes, Valerie A.
    Patterson, Chris C.
    Young, Ian S.
    Mccance, David
    DIABETES, 2016, 65 : A352 - A352
  • [33] Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
    Furuhashi, Masato
    Sakuma, Ichiro
    Morimoto, Takeshi
    Higashiura, Yukimura
    Sakai, Akiko
    Matsumoto, Megumi
    Sakuma, Mio
    Shimabukuro, Michio
    Nomiyama, Takashi
    Arasaki, Osamu
    Node, Koichi
    Ueda, Shinichiro
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [34] Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy
    Masato Furuhashi
    Ichiro Sakuma
    Takeshi Morimoto
    Yukimura Higashiura
    Akiko Sakai
    Megumi Matsumoto
    Mio Sakuma
    Michio Shimabukuro
    Takashi Nomiyama
    Osamu Arasaki
    Koichi Node
    Shinichiro Ueda
    Cardiovascular Diabetology, 19
  • [35] Candida albicans Induces Foaming and Inflammation in Macrophages through FABP4: Its Implication for Atherosclerosis
    Alrashed, Fatema
    Haider, Mohammed
    Albaqsumi, Zahraa
    Alobaid, Khalid
    Alqabandi, Rawan
    Al-Mulla, Fahd
    Ahmad, Rasheed
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [36] Circulating FABP4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication
    Furuhashi, Masato
    Yuda, Satoshi
    Muranaka, Atsuko
    Kawamukai, Mina
    Matsumoto, Megumi
    Tanaka, Marenao
    Moniwa, Norihito
    Ohnishi, Hirofumi
    Saitoh, Shigeyuki
    Shimamoto, Kazuaki
    Miura, Tetsuji
    CIRCULATION, 2017, 136
  • [37] FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes
    Vorobjova, Tamara
    Tagoma, Aili
    Talja, Ija
    Janson, Helis
    Kirss, Anne
    Uibo, Raivo
    JOURNAL OF DIABETES RESEARCH, 2022, 2022
  • [38] Fatty Acid Binding Protein 4, FABP4, Causes Impaired Wound Healing in Diabetes
    Boniakowski, Anna
    Kimball, Andrew
    Davis, Frank
    Joshi, Amrita
    Schaller, Matt
    denDekker, Aaron
    Kunkel, Steve
    Gallagher, Katherine
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [39] Candida albicans Induces Foaming and Inflammation in Macrophages through FABP4: Its Implication for Atherosclerosis
    Haider, Mohammed
    Al-Rashed, Fatema
    Albaqsumi, Zahraa
    Alobaid, Khaled
    Alqabandi, Rawan
    Al-Mulla, Fahd
    Ahmad, Rasheed
    BIOMEDICINES, 2021, 9 (11)
  • [40] Therapeutic potential of a synthetic FABP4 inhibitor 8g on atherosclerosis in ApoE-deficient mice: the inhibition of lipid accumulation and inflammation (vol 6, pg 52518, 2016)
    Pei, Heying
    Xie, Caifeng
    Liu, Yibin
    Shao, Mingfeng
    Chen, Jinying
    Li, Dan
    Ma, Liang
    Chen, Lijuan
    RSC ADVANCES, 2017, 7 (17): : 10432 - 10432
12345